中国翰森制药周一表示，其旗下单位已与罗氏达成合作与许可协议，潜在价值超过15亿美元，涵盖一系列抗体药物偶联物项目。
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion Oct 19 - China's Hansoh Pharmaceutical said on Monday its units have entered into a collaboration and licensing deal with Roche potentially worth more than $15 billion, covering a portfolio of antibody-drug conjugate programs.
根据协议，翰森将获得4亿美元的预付款、1.1亿美元的一周年纪念付款以及进一步的里程碑付款。
Under the deal, Hansoh will receive an upfront payment of $400 million, a first anniversary payment of $110 million, and further milestone payments.